Explore how Moderna's (MRNA) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Despite concerns, there was no significant increase in sudden cardiac arrest (SCA) among young athletes during the COVID-19 ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced ...

New research from the Perelman School of Medicine at the University of Pennsylvania suggests that a combination of messenger ...

With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...

Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...

Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for ...

The results of this study suggest that mRNA COVID-19 vaccination may be a protective factor against post–COVID-19 condition ...

The Avestagenome Project® International Pvt. Ltd. (AGENOME) & Avesthagen Limited, in partnership with the Tata Institute for ...

The Trump administration has started quietly re-hiring some of the FDA employees that it fired last week in a process that insiders called abrupt and haphazard, STAT’s Lizzy Lawrence reports. The ...